Neurolief
Neurolief
Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders like migraine and depression.
About
Technology stack
detected 2026-07-01No comments yet. Be the first to share your take.
What does Neurolief do?
Neurolief is a medical device company focused on developing non-invasive neuromodulation technology for the treatment of neurological and neuropsychiatric disorders. Their primary product, the Relivion system, is a brain neuromodulation device designed to provide relief for conditions such as migraine and depression by stimulating specific brain regions.
How much funding has Neurolief raised?
Neurolief has raised a total of $15M in funding. The most recent round on record is Series A.
Where is Neurolief headquartered?
Neurolief is headquartered in Netanya, Israel.
When was Neurolief founded?
Neurolief was founded in 2013.
What industry does Neurolief operate in?
Neurolief operates in Healthcare, Brain, Migraine, Neuromodulation, Wearable, MedTech.
How many employees does Neurolief have?
Neurolief has approximately 30 people on record.